The MG Clinical & Patient Insight Challenge
Reviewed by: HU Medical Review Board | Last reviewed: March 2026 | Last updated: March 2026
Welcome to the myasthenia gravis (MG) Clinical & Patient Insight Challenge. This quiz bridges the gap between advanced pathophysiology and the real-world experiences of the MG community.
Quick Quiz
According to the long-term follow-up of the MGTX trial and the 2020 International Consensus Guidance, which patient profile is most likely to benefit from a thymectomy in the absence of a thymoma?
Quick Quiz
Before initiating a complement inhibitor such as ravulizumab for a patient with refractory generalized MG, which of the following is a mandatory safety requirement?
Quick Quiz
Which of the following statements best describes the clinical utility of single-fiber electromyography (SFEMG) in the diagnostic workup of a patient with suspected myasthenia gravis?
Quick Quiz
In a patient treated with cyclic FcRn therapy, which clinical scenario most strongly indicates that it may be time to switch to a different class of therapy?
Quick Quiz
In the context of 'triple-seronegative' generalized MG, which of the following proteins is a reported target of autoantibodies that can disrupt the LRP4-MuSK signaling complex?